REFILE-FDA puts clinical hold on Seattle Genetics' cancer drug after 4 deaths

Dec 27 (Reuters) - Seattle Genetics Inc said on

Tuesday that four people had died in trials testing its

experimental cancer drug, prompting the U.S. Food and Drug

Administration to impose a clinical...

Read more